VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cytokine1 who wrote (6151)	12/21/1998 11:12:00 PM
From: Biomaven	Read Replies (2) of 9719

IMUL is worth a look for the value-oriented biotech investor (kind of an oxymoron, I guess). After its latest deal: prnewswire.com it is basically a shell, with lots more cash than market cap, and a chance at some upside if any of its licensed products work out. (Something I haven't a clue about). There's a risk, of course, that they'll just sit on their cash and decorate their offices 'til it's all gone. But if there wasn't a little bit of risk it wouldn't be a proper biotech investment now would it? <G> Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next